We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pharmerica Corp. (delisted) | NYSE:PMC | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.25 | 0.00 | 01:00:00 |
Delaware
|
001-33380
|
87-0792558
|
(State of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.02 |
Termination of a Material Definitive Agreement.
|
Item 2.01. |
Completion of Acquisition or Disposition of Assets.
|
Item 3.01. |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
|
Item 3.03. |
Material Modification to Rights of Security Holders.
|
Item 5.01. |
Change in Control of Registrant.
|
Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Item 5.03. |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
Item 8.01 |
Other Events
|
Item 9.01 |
Financial Statements and Exhibits.
|
Exhibit
|
Description of Exhibit
|
|
Amended and Restated Certificate of Incorporation of
PharMerica Corporation
|
||
Amended and Restated Bylaws of
PharMerica Corporation
|
||
Press Release, dated December 7, 2017
|
PharMerica Corporation
|
||||
By:
|
/s/ Thomas Caneris
|
|||
Name:
|
Thomas Caneris
|
|||
Title:
|
Senior Vice President, General Counsel and Secretary
|
1 Year Pharmerica Corp. (delisted) Chart |
1 Month Pharmerica Corp. (delisted) Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions